Pharmacology and clinical evaluation of rufinamide, a new antiepileptic drugsFENG Yu-fei, XU Qiao-ling, LI Wen-ying, FU De-xing1182-1185
Application of defense principle of publicly known technology in the drug patent infringement litigationCHEN Jing, JIANG Bin, SHI Lu-wen1186-1188,1273
Management measures of drug risk and its application in the case of LotronexWEI Jing, PAN Wei-san, YANG Yue1189-1192
Supplemental submission of application for investigational new drugs in ChinaYANG Zhi-min, WEN Bao-shu, SHI Ji-feng, HE Yan-ping, YANG Jian-hong, FENG Yi1193-1195,1242
The present situation and development direction of the research for polymorphic drugs in ChinaQIANG Gui-fen, L(U) Yang, DU Guan-hua1196-1200
Progress in the research of the interleukin-1 blocker rilonaceptSHI Zheng-yuan, CAO Guo-ying, FU De-xing, HU Xin, CHEN Xiao-hui, BI Kai-shun1201-1203,1210
Classification and application of proteins from snake venomCHEN Nian, FU Xiao-yan, JIANG Wei-jian, ZHAO Shu-jin1204-1210
Analysis of 101 cases for the treatment of hiccup with granisetronZHANG Jun-kai, KANG Gou-qiang, BAI Xiu-li, GAO Fu-lan1211-1212,1236
Effect of Fufang Danshen Diwan on the cognitive function of diabetic patients complicated with coronary heart diseaseLIN Jia-yi, LIU Jia-he, LIU Xian-hua, GU Dong-fang1213-1216
Compound Danshen Diwan combined with fluvastatin inhibits formation of carotid atherosclerotic plaquesDONG Bing-qing, GE Bin, FENG Xia, CHEN Ai-fang1217-1219